Skip to main content

Upper Gastrointestinal Hemorrhage clinical trials at UC Health
1 research study open to new patients

  • Standard Endoscopic Hemostasis Versus OVESCO Severe Non-variceal UGI Hemorrhage

    open to eligible people ages 18-100

    The primary specific aim is to perform a randomized controlled trial (RCT) to compare the rebleeding rates and other clinical outcomes of severe, refractory or recurrent non-variceal upper GI hemorrhage (NVUGIH) with a new over-the-scope hemoclipping device (OVESCO) versus standard endoscopic hemostasis.

    at UCLA

Last updated: